Abstract

Objective: Evaluation of characteristics and relations of sarcopenia by the formula Ishii in the type 2 diabetes mellitus olders. Methods: A cross-sectional study on 302 patients type 2 diabetes mellitus admitted at the National hospital of endocrinology from March 2022 to May 2022. Results: The prevalence of sarcopenia was 26.2% (males: 34.3% and females: 19.4%); ≥ 70 ages: 51.5%, in group < 70 ages: 6.5%; countryside: 30.7%, in group city: 20.6%; in group BMI < 23.0: 31.7%, BMI ≥ 23.0: 21.5%; in group eGFR < 60ml/min/1.73m2 : 38.7%, ≥ 60ml/min/1.73m2 : 9.3%; in group taking metformin: 20.4%, not taking metformin: 35.3%. The rate of sarcopenia increased 15.358 times who were more than 70 ages (95% CI, OR: 7.627-30.925, p < 0.001); increased 1.711 times in patients living countryside (95% CI, OR: 1.006-2.908, p = 0.046); increased 1.684 times in patients with BMI < 23.0 (95% CI, OR: 1.010-2.841, p = 0.045); increased 6.163 times in patients with eGFR < 60ml/phút/1.73m2 (95% CI, OR: 3.159-12.022, p < 0.001); decreased 0.470 times in patients taking metformin (95% CI, OR: 0.279-0.791, p = 0.004). Conclusion: The prevalence of sarcopenia was 26.2% (males: 34.3% and females: 19.4%). It related to age, gender, living area, BMI, eGFR and taking metformin